Aspirin Cardio tablets are intended for the following cardiovascular use: Reducing the risk of mortality in patients with suspected acute myocardial infarction. Reducing the risk of morbidity and mortality in patients with previous myocardial infarction. Secondary prevention of stroke. Reducing the risk of temporary ischemic attacks and stroke in patients with transient ischemia. Reducing the risk of morbidity and mortality in patients with stable and unstable angina. Prevention of thromboembolism after blood vessel surgery or surgery such as PTCA, CABG, carotid endarterectomy, arteriovenous shunting. Reducing the risk of deep vein thrombosis and pulmonary embolism after prolonged immobility, such as after major surgeries. Reducing the risk of first myocardial infarction in people with cardiovascular risk factors, for example, diabetes mellitus, hyperlipidemia, hypertension, obesity, in smokers, in the elderly.
Related products
